Copyright
        ©2005 Baishideng Publishing Group Inc.
    
    
        World J Gastroenterol. May 14, 2005; 11(18): 2720-2725
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2720
Published online May 14, 2005. doi: 10.3748/wjg.v11.i18.2720
            Table 1 Effect of sample storage.
        
    | H pylori positivepatients | D1 | D2 | ||||
| Rh123 MF | Rh123+CsA MF | RMF | Rh123 MF | Rh123+CsA MF | RMF | |
| 1 | 73.14 | 124.58 | 1.703 | 25.00 | 44.76 | 1.790 | 
| 2 | 75.25 | 17.86 | 0.237 | 27.83 | 4.28 | 0.157 | 
| 3 | 5.47 | 20.85 | 3.404 | 17.25 | 41.72 | 2.419 | 
| 4 | 83.40 | 113.79 | 1.364 | 43.03 | 61.20 | 1.423 | 
| 5 | 83.40 | 113.79 | 1.364 | 90.44 | 172.18 | 1.920 | 
| 6 | 141.21 | 68.47 | 0.485 | 72.91 | 80.63 | 1.106 | 
| 7 | 72.31 | 223.19 | 3.087 | 46.72 | 223.44 | 4.783 | 
| 8 | 262.30 | 220.78 | 0.842 | 308.4 | 326.90 | 1.06 | 
| 9 | 135.53 | 93.90 | 0.693 | 36.71 | 255.95 | 6.972 | 
| 10 | 170.21 | 225.35 | 1.324 | 220.95 | 223.71 | 1.012 | 
| 11 | 115.20 | 165.20 | 1.434 | 37.88 | 94.26 | 2.288 | 
| 12 | 11.30 | 25.10 | 2.221 | 25.76 | 134.78 | 5.332 | 
| RMF (mean±SD) | 1.427±1.034 | 2.522±2.067 | ||||
            Table 2 Role of pretherapeutic determination of Pgp activity.
        
    | Variables | Therapy cycle | B/A and controls | |||
| H pylori positive | H pylorinegative | ||||
| 1 = A (n = 20) | 2 or more = B (n = 33) | NO (n = 12) | Pa | Beta Pb | |
| Age (yr) | 47.5±8.8 | 47.3±13.7 | 48.3±16.5 | 0.973 | 0.152 | 
| Sex (M/ F) | 9/11 | 15/18 | 5/7 | 0.975 | 0.153 | 
| DHP | 2.75±0.91 | 2.90±0.97 | 1.0±0.0 | 0.00001 | 0.00065 | 
| DIEn | 2.65±0.81 | 3.06±0.86 | 1.0±0.0 | 0.00001 | 0.45 | 
| RMF (mean±SD) | 0.889±0.28 | 1.647±0.65 | 0.787±0.29 | 0.00001 | 0.000005 | 
            Table 3 Impact of initial values on H pylori eradication efficacy.
        
    | Variable | Final eradication of H pylori | P | |
| Successful (n = 31) | Unsuccessful (n = 22) | ||
| Age (yr) | 46.54±12.51 | 48.54±11.44 | 0.556 | 
| Sex (M/F) | 15/16 | 9/13 | 0.598 | 
| DHP | 2.90±0.97 | 2.77±0.92 | 0.626 | 
| DIEn | 2.77±0.846 | 3.09±0.86 | 0.189 | 
| RMF (mean±SD) | 1.26±0715 | 1.54±0.66 | 0.13418 | 
- 
        Citation: Babic Z, Svoboda-Beusan I, Kucisec-Tepes N, Dekaris D, Troskot R. Increased activity of Pgp multidrug transporter in patients with Helicobacter pylori infection. World J Gastroenterol 2005; 11(18): 2720-2725
- URL: https://www.wjgnet.com/1007-9327/full/v11/i18/2720.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i18.2720

 
         
                         
                 
                 
                 
                 
         
                         
                         
                        